1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBiomedical Technologies (BM) - National Science Foundation (NSF) SBIR is sponsored by National Science Foundation (NSF) SBIR/STTR. The Biomedical Technologies topic aims to support the early-stage development of novel products, processes, or services that will enable the delivery of high-quality, economically efficient healthcare.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Biomedical Technologies Grant – Apply Today | NSF SBIR For proposal preparation and submission instructions, click here . The SBIR/STTR program looks forward to receiving the submission of new Project Pitches in response to the new solicitations beginning on Tuesday, June 2, 2026. Please direct any questions to sbir@nsf.
gov . Biomedical Technologies (BM) Biomedical Technologies (BM) The Biomedical Technologies topic aims to support the early-stage development of novel products, processes or services that will enable the delivery of high-quality, economically efficient healthcare.
Subtopics are not aimed at supporting or conducting clinical trials, clinical efficacy or safety studies, the development pre-clinical or clinical-stage drug candidates or medical devices, or work performed primarily for regulatory purposes. Limited studies with human subjects may be acceptable to the extent that they are performed in support of feasibility, such as proof-of-concept studies of early-stage technologies.
Proposals that request support for clinical studies will be deemed noncompliant with the SBIR/STTR solicitations and returned without review. BM2. Drug Delivery Methods BM3.
Materials for Biomedical Applications BM6. Other Biomedical Technologies Application process for Biomedical Technologies (BM) funding Eligibility for Biomedical Technologies (BM) funding + Your company must be a small business (fewer than 500 employees) located in the United States. At least 50% of your company’s equity must be owned by U.S. citizens or permanent residents.
NSF does not fund companies that are majority-owned by multiple venture capital firms, private equity firms, or hedge funds, to participate in SBIR and STTR. All funded work, including work done by consultants and contractors, needs to take place in the United States. The project’s principal investigator (tech lead) must be legally employed at least 20 hours a week by the company seeking funding.
The principal investigator doesn’t need any advanced degrees. The principal investigator needs to commit to at least one month (173 hours) of work on a funded project per six months of project duration. Evaluation Criteria: What We Look for When Evaluating Biomedical Technologies (BM) proposals + Take our project assessment to see if your work might be a good fit for NSF funding.
Engineering bacteria to treat skin disease Azitra, a small business funded by the National Science Foundation (NSF), is harnessing the microbiome to treat skin disease. To learn more visit: https://azitrainc.
com/ Blood cleansing device removes pathogens Path Ex is developing a device to remove pathogens from blood and treat drug-resistant bacteria and endotoxins from circulating blood, which could be used in the treatment of bacteremia and sepsis. To learn more visit: https://pathex. co/ We invest up to $2 million in seed funding and take zero equity.
We’re looking for companies that are transformative, high-risk, have a market pull, and are scaleable.
According to the current listing, eligibility includes: Small businesses (fewer than 500 employees) located in the United States, with at least 50% equity owned by U. S. citizens or permanent residents. Confirm the full requirements in the official notice before applying.
The current listing shows up to $305,000 for Phase I, up to $1,250,000 for Phase II. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Biomedical Technologies (BM) - National Science Foundation (NSF) SBIR is funded by National Science Foundation (NSF) SBIR/STTR. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NSF's restarted SBIR/STTR program carries two transition rules almost nobody has calendared. Project Pitch invitations issued on or after July 3, 2025 must be converted to a full proposal by November 4, 2026. Phase I awardees whose awards started on or after November 6, 2023 must submit Phase II by the same date. Both cohorts were created by the program lapse, and both cliffs are hard.
Read articleNSF's rebuilt SBIR/STTR program (NSF 26-510) pairs a $305,000 Phase I with a brand-new Strategic Breakthrough award worth up to $30 million for the strongest Phase II companies. The next Project Pitch deadline is July 27, 2026. Here is how the non-dilutive funding ladder now works, why the Project Pitch gate decides everything, and how a founder should sequence the next twelve months.
Read articleAfter a disruptive pause, NSF has reopened its SBIR/STTR programs with $250 million for deep-tech startups — including a $40M scientific-instrumentation pilot and a new Strategic Breakthrough track that can reach $30 million. The first Project Pitch deadline is July 27, 2026. Here is how the reopened pipeline works, why the Project Pitch is the real gate, and how founders should sequence a submission before the window narrows.
Read article